We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mapping Human Proteins Will Help Identify Diseases

By LabMedica International staff writers
Posted on 27 Oct 2008
Swedish scientists are creating an atlas of the proteins in the human's body tissues and cells. More...
The atlas should enlighten scientists about the function of the proteins and how changes in their distribution could be reflected in certain diseases such as cancer.

The protein atlas team uses the human genome to encode individual proteins. Antibodies are then developed against each of these proteins. The antibody that recognizes a given protein is then labeled with a marker to render it visible under a microscope and is exposed to samples of different tissues and cells. The antibody binds to the proteins and in this way, the location of the protein can be detected.

Functional genomics describes the way in which genes and their products, proteins, interact together in complex networks in living cells. Professor Mathias Uhlén of the Royal Institute of Technology (KTH; Stockholm, Sweden), who is leading the project, described the human protein atlas at the European Science Foundation's Third Functional Genomics Conference in Innsbruck, Austria, on October 1-4, 2008.

The protein atlas project is a very ambitious. "To do this systematically requires a lot of automation and robotics," Professor Uhlén said. "We have six software engineers writing codes just to keep track of the samples. The project is generating 400 gigabytes of data every day." There is a 100-strong team working on the project, with a site due to be set up soon in India, and with antibody-producing sites in Korea and China.

The team has so far mapped the location of around 5000 proteins in human cells and tissues. The scientists are investigating whether certain common cancers--colon, prostate, lung, and breast--have different protein profiles to normal tissue. In this way, new biomarkers can be identified, which could alert doctors to the early stages of a disease.

Related Links:
Royal Institute of Technology



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Automated PCR System
OnePCR
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.